Contact Us   |   Print Page   |   Sign In   |   Join
BioArbor: The Good, The Bad, The Ugly of Startups
Tell a Friend About This EventTell a Friend

When: September 16, 2015
5:00-7:00 p.m.
Where: Ann Arbor SPARK Central
330 E. Liberty Street
Lower Level
Ann Arbor, Michigan  48104
United States
Contact: Dave McGuire

Online registration is closed.
« Go to Upcoming Event List  





Serial Entrepreneurs Share their Stories:

The Good, the Bad and the Ugly of Startups

Starting and running a start-up company is hard work, with many surprises along the way. From investors acting badly to founders with different visions, almost anything can happen. Some of the best experience comes from actually being in the trenches. Join three respected serial entrepreneurs/CEOs for an open discussion about their experiences building companies. Panelists will share their history as well as tips and key mistakes to avoid.  Learn from their experience and help your life science start-up succeed. Plenty of time to follow for Q&A and lively discussion.

Panelists include:

Kent Hawryluk
Kent Hawryluk is based in San Diego and Indianapolis with senior roles at two companies he co-founded: Avidity, a pioneer in precision nanomedicines; and MB2, a clinical stage company focused in diabetes and obesity. Kent was previously Co-Founder/Chief Business Officer of Marcadia Biotech, which was acquired by Roche in late 2010. He has been a partner at Twilight Venture Partners for over 12 years.  Kent is pleased to be on the board of a Michigan company, Gemphire Therapeutics.

Handique Kalyan
Dr. Kalyan “Handy” Handique is currently the President, Chief Executive Officer, and Director of Denovo Sciences, Inc. Denovo Sciences is bringing cutting-edge circulating tumor cell detection technology to the cancer research and clinical markets. Handy co-founded HandyLab, a start-up molecular diagnostic company, in 2000.  Becton Dickinson (BD) Diagnostic Systems acquired HandyLab in a landmark deal valued at more than $275 million. In addition, Handy also serves on several boards including 3D Biomatrix (chairman) and PhasiQ Inc.

Laura Schrader
Laura Schrader is the President & CEO of 3D Biomatrix, Inc. 3D Biomatrix’s unique products make it simple to integrate 3D cell culture into discovery research, allowing scientists to achieve a more human-mimicking environment for cell biology, cancer and stem cell research and more. With over 20 years’ experience working with and launching new ventures in different industries, Laura believes the key to leading companies is constantly taking action and staying agile while keeping an eye on strategy to ensure the company reaches its best commercial potential.  


Learn more about BioArbor.





Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership  ::  Legal